A phase II multi-institutional study assessing simultaneous in-field boost helical tomotherapy for 1-3 brain metastases View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2012-12

AUTHORS

George Rodrigues, Slav Yartsev, Keng Yeow Tay, Gregory R Pond, Frank Lagerwaard, Glenn Bauman

ABSTRACT

BACKGROUND: Our research group has previously published a dosimetric planning study that demonstrated that a 60 Gy/10 fractions intralesional boost with whole-brain radiotherapy (WBRT) to 30 Gy/10 fractions was biologically equivalent with a stereotactic radiosurgery (SRS) boost of 18 Gy/1 fraction with 30 Gy/10 fractions WBRT. Helical tomotherapy (HT) was found to be dosimetrically equivalent to SRS in terms of target coverage and superior to SRS in terms of normal tissue tolerance. A phase I trial has been now completed at our institution with a total of 60 enrolled patients and 48 evaluable patients. The phase II dose has been determined to be the final phase I cohort dose of 60 Gy/10 fractions. METHODS/DESIGN: The objective of this clinical trial is to subject the final phase I cohort dose to a phase II assessment of the endpoints of overall survival, intracranial control (ICC) and intralesional control (ILC). We hypothesize HT would be considered unsuitable for further study if the median OS for patients treated with the HT SIB technique is degraded by 2 months, or the intracranial progression-free rates (ICC and ILC) are inferior by 10% or greater compared to the expected results with treatment by whole brain plus SRS as defined by the RTOG randomized trial. A sample size of 93 patients was calculated based on these parameters as well as the statistical assumptions of alpha = 0.025 and beta = 0.1 due to multiple statistical testing. Secondary assessments of toxicity, health-related quality-of-life, cognitive changes, and tumor response are also integrated into this research protocol. DISCUSSION: To summarize, the purpose of this phase II trial is to assess this non-invasive alternative to SRS in terms of central nervous system (CNS) control when compared to SRS historical controls. A follow-up phase III trial may be required depending on the results of this trial in order to definitively assess non-inferiority/superiority of this approach. Ultimately, the purpose of this line of research is to provide patients with metastatic disease to the brain a shorter course, dose intense, non-invasive radiation treatment with equivalent or improved CNS control/survival and health-related quality-of-life/toxicity profile when compared to SRS radiotherapy. TRIAL REGISTRATION: Clinicaltrials.gov - NCT01543542. More... »

PAGES

42

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/1748-717x-7-42

DOI

http://dx.doi.org/10.1186/1748-717x-7-42

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1027926222

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/22436144


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Brain Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cranial Irradiation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Research Design", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Western University", 
          "id": "https://www.grid.ac/institutes/grid.39381.30", 
          "name": [
            "Division of Radiation Oncology, Department of Oncology, University of Western Ontario and London Regional Cancer Program, London Health Sciences Centre,University of Western Ontario and London Regional Cancer Program, N6A4L6, London, ON, Canada", 
            "Department of Epidemiology and Biostatistics, University of Western Ontario, N6A3K7, London, ON, Canada", 
            "790 Commissioners Rd. E, N6A4L6, London, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rodrigues", 
        "givenName": "George", 
        "id": "sg:person.0676000441.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0676000441.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Western University", 
          "id": "https://www.grid.ac/institutes/grid.39381.30", 
          "name": [
            "Department of Medical Biophysics, University of Western Ontario, N6A4L6, London, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yartsev", 
        "givenName": "Slav", 
        "id": "sg:person.01002230243.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01002230243.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "London Health Sciences Centre", 
          "id": "https://www.grid.ac/institutes/grid.412745.1", 
          "name": [
            "Department of Medical Imaging, London Health Sciences Centre, N6A4L6, London, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tay", 
        "givenName": "Keng Yeow", 
        "id": "sg:person.01252126745.68", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01252126745.68"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "McMaster University", 
          "id": "https://www.grid.ac/institutes/grid.25073.33", 
          "name": [
            "Department of Oncology, McMaster University and Escarpment Cancer Research Institute, L8V1C3, Hamilton, Ontario, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pond", 
        "givenName": "Gregory R", 
        "id": "sg:person.01251570265.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01251570265.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "VU University Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.16872.3a", 
          "name": [
            "Department of Radiation Oncology, VU University Medical Center, de Boelelaan 1117, 1081, HV Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lagerwaard", 
        "givenName": "Frank", 
        "id": "sg:person.01126413317.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01126413317.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Western University", 
          "id": "https://www.grid.ac/institutes/grid.39381.30", 
          "name": [
            "Division of Radiation Oncology, Department of Oncology, University of Western Ontario and London Regional Cancer Program, London Health Sciences Centre,University of Western Ontario and London Regional Cancer Program, N6A4L6, London, ON, Canada", 
            "Department of Medical Biophysics, University of Western Ontario, N6A4L6, London, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bauman", 
        "givenName": "Glenn", 
        "id": "sg:person.0627666704.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0627666704.37"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2004.07.629", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003359041"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0360-3016(99)00213-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003614610"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1053-4296(99)80058-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004013743"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2005.05.023", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005827550"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2005.05.023", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005827550"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2006.11.052", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010144498"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0360-3016(96)00619-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014462056"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ctrv.2005.04.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021728921"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ctrv.2005.04.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021728921"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0360-3016(89)90506-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022235183"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2010.03.047", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025173793"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(04)16250-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038506523"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0360-3016(99)00198-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038891858"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2007.06.074", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040065986"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0167-8140(03)00117-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041826131"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0167-8140(03)00117-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041826131"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.radonc.2011.05.032", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041892439"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0360-3016(93)90367-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044677784"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0360-3016(95)02106-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046204369"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0360-3016(99)00340-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047679955"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.coc.0000245473.41035.c4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048339781"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.coc.0000245473.41035.c4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048339781"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1118/1.1945347", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053586021"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0360-3016(04)01933-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1054653816"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1259/bjr/22666727", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064568490"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2012-12", 
    "datePublishedReg": "2012-12-01", 
    "description": "BACKGROUND: Our research group has previously published a dosimetric planning study that demonstrated that a 60 Gy/10 fractions intralesional boost with whole-brain radiotherapy (WBRT) to 30 Gy/10 fractions was biologically equivalent with a stereotactic radiosurgery (SRS) boost of 18 Gy/1 fraction with 30 Gy/10 fractions WBRT. Helical tomotherapy (HT) was found to be dosimetrically equivalent to SRS in terms of target coverage and superior to SRS in terms of normal tissue tolerance. A phase I trial has been now completed at our institution with a total of 60 enrolled patients and 48 evaluable patients. The phase II dose has been determined to be the final phase I cohort dose of 60 Gy/10 fractions.\nMETHODS/DESIGN: The objective of this clinical trial is to subject the final phase I cohort dose to a phase II assessment of the endpoints of overall survival, intracranial control (ICC) and intralesional control (ILC). We hypothesize HT would be considered unsuitable for further study if the median OS for patients treated with the HT SIB technique is degraded by 2 months, or the intracranial progression-free rates (ICC and ILC) are inferior by 10% or greater compared to the expected results with treatment by whole brain plus SRS as defined by the RTOG randomized trial. A sample size of 93 patients was calculated based on these parameters as well as the statistical assumptions of alpha = 0.025 and beta = 0.1 due to multiple statistical testing. Secondary assessments of toxicity, health-related quality-of-life, cognitive changes, and tumor response are also integrated into this research protocol.\nDISCUSSION: To summarize, the purpose of this phase II trial is to assess this non-invasive alternative to SRS in terms of central nervous system (CNS) control when compared to SRS historical controls. A follow-up phase III trial may be required depending on the results of this trial in order to definitively assess non-inferiority/superiority of this approach. Ultimately, the purpose of this line of research is to provide patients with metastatic disease to the brain a shorter course, dose intense, non-invasive radiation treatment with equivalent or improved CNS control/survival and health-related quality-of-life/toxicity profile when compared to SRS radiotherapy.\nTRIAL REGISTRATION: Clinicaltrials.gov - NCT01543542.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/1748-717x-7-42", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1036451", 
        "issn": [
          "1748-717X"
        ], 
        "name": "Radiation Oncology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "7"
      }
    ], 
    "name": "A phase II multi-institutional study assessing simultaneous in-field boost helical tomotherapy for 1-3 brain metastases", 
    "pagination": "42", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "85080aa291609bb2925c5be34eecca348a9b7fab766f9ef56e2a6809091e834e"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "22436144"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101265111"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/1748-717x-7-42"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1027926222"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/1748-717x-7-42", 
      "https://app.dimensions.ai/details/publication/pub.1027926222"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T15:56", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8664_00000537.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1186%2F1748-717X-7-42"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1748-717x-7-42'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1748-717x-7-42'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1748-717x-7-42'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1748-717x-7-42'


 

This table displays all metadata directly associated to this object as RDF triples.

194 TRIPLES      21 PREDICATES      54 URIs      25 LITERALS      13 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/1748-717x-7-42 schema:about N49eaced71b5548c395de0649af991d96
2 N7f5109159c1e4639b8c977482b463b88
3 N7f927da223cc45c79092c9c1d0a1cad9
4 Na923d73be5ae458f8d07787ba5a48c4c
5 anzsrc-for:11
6 anzsrc-for:1112
7 schema:author Na7412f4c416f40b3920329db3b2ed27f
8 schema:citation https://doi.org/10.1016/0360-3016(89)90506-3
9 https://doi.org/10.1016/0360-3016(93)90367-5
10 https://doi.org/10.1016/0360-3016(95)02106-x
11 https://doi.org/10.1016/j.ctrv.2005.04.007
12 https://doi.org/10.1016/j.ijrobp.2004.07.629
13 https://doi.org/10.1016/j.ijrobp.2005.05.023
14 https://doi.org/10.1016/j.ijrobp.2006.11.052
15 https://doi.org/10.1016/j.ijrobp.2007.06.074
16 https://doi.org/10.1016/j.ijrobp.2010.03.047
17 https://doi.org/10.1016/j.radonc.2011.05.032
18 https://doi.org/10.1016/s0140-6736(04)16250-8
19 https://doi.org/10.1016/s0167-8140(03)00117-8
20 https://doi.org/10.1016/s0360-3016(04)01933-9
21 https://doi.org/10.1016/s0360-3016(96)00619-0
22 https://doi.org/10.1016/s0360-3016(99)00198-4
23 https://doi.org/10.1016/s0360-3016(99)00213-8
24 https://doi.org/10.1016/s0360-3016(99)00340-5
25 https://doi.org/10.1016/s1053-4296(99)80058-7
26 https://doi.org/10.1097/01.coc.0000245473.41035.c4
27 https://doi.org/10.1118/1.1945347
28 https://doi.org/10.1259/bjr/22666727
29 schema:datePublished 2012-12
30 schema:datePublishedReg 2012-12-01
31 schema:description BACKGROUND: Our research group has previously published a dosimetric planning study that demonstrated that a 60 Gy/10 fractions intralesional boost with whole-brain radiotherapy (WBRT) to 30 Gy/10 fractions was biologically equivalent with a stereotactic radiosurgery (SRS) boost of 18 Gy/1 fraction with 30 Gy/10 fractions WBRT. Helical tomotherapy (HT) was found to be dosimetrically equivalent to SRS in terms of target coverage and superior to SRS in terms of normal tissue tolerance. A phase I trial has been now completed at our institution with a total of 60 enrolled patients and 48 evaluable patients. The phase II dose has been determined to be the final phase I cohort dose of 60 Gy/10 fractions. METHODS/DESIGN: The objective of this clinical trial is to subject the final phase I cohort dose to a phase II assessment of the endpoints of overall survival, intracranial control (ICC) and intralesional control (ILC). We hypothesize HT would be considered unsuitable for further study if the median OS for patients treated with the HT SIB technique is degraded by 2 months, or the intracranial progression-free rates (ICC and ILC) are inferior by 10% or greater compared to the expected results with treatment by whole brain plus SRS as defined by the RTOG randomized trial. A sample size of 93 patients was calculated based on these parameters as well as the statistical assumptions of alpha = 0.025 and beta = 0.1 due to multiple statistical testing. Secondary assessments of toxicity, health-related quality-of-life, cognitive changes, and tumor response are also integrated into this research protocol. DISCUSSION: To summarize, the purpose of this phase II trial is to assess this non-invasive alternative to SRS in terms of central nervous system (CNS) control when compared to SRS historical controls. A follow-up phase III trial may be required depending on the results of this trial in order to definitively assess non-inferiority/superiority of this approach. Ultimately, the purpose of this line of research is to provide patients with metastatic disease to the brain a shorter course, dose intense, non-invasive radiation treatment with equivalent or improved CNS control/survival and health-related quality-of-life/toxicity profile when compared to SRS radiotherapy. TRIAL REGISTRATION: Clinicaltrials.gov - NCT01543542.
32 schema:genre research_article
33 schema:inLanguage en
34 schema:isAccessibleForFree true
35 schema:isPartOf N87a50a20d154421282c0cecf9e1c696d
36 Nb93791d8a82a499e8621a02055c3468c
37 sg:journal.1036451
38 schema:name A phase II multi-institutional study assessing simultaneous in-field boost helical tomotherapy for 1-3 brain metastases
39 schema:pagination 42
40 schema:productId N5cb40096faba423cae18edb5e7b55a96
41 N5ec0ea2104e147f9ac21bdbc04dc19a7
42 N89190dcf70734be2819879eb9b5aa44a
43 N8e8908e8d51a461bb7f89c4c47a0e919
44 Nd22e45a8df8342b69abb23bc4766e08e
45 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027926222
46 https://doi.org/10.1186/1748-717x-7-42
47 schema:sdDatePublished 2019-04-10T15:56
48 schema:sdLicense https://scigraph.springernature.com/explorer/license/
49 schema:sdPublisher N01c2d0f32b2948c4a19c2febbcb3f69d
50 schema:url http://link.springer.com/10.1186%2F1748-717X-7-42
51 sgo:license sg:explorer/license/
52 sgo:sdDataset articles
53 rdf:type schema:ScholarlyArticle
54 N01c2d0f32b2948c4a19c2febbcb3f69d schema:name Springer Nature - SN SciGraph project
55 rdf:type schema:Organization
56 N030359b112be473da547a5b8c028cda8 rdf:first sg:person.01252126745.68
57 rdf:rest N4b752dfd83484990a43338697f3826a5
58 N49eaced71b5548c395de0649af991d96 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
59 schema:name Humans
60 rdf:type schema:DefinedTerm
61 N4b752dfd83484990a43338697f3826a5 rdf:first sg:person.01251570265.35
62 rdf:rest N6e620db0bdf748f38b68e9348171eb72
63 N5cb40096faba423cae18edb5e7b55a96 schema:name readcube_id
64 schema:value 85080aa291609bb2925c5be34eecca348a9b7fab766f9ef56e2a6809091e834e
65 rdf:type schema:PropertyValue
66 N5ec0ea2104e147f9ac21bdbc04dc19a7 schema:name dimensions_id
67 schema:value pub.1027926222
68 rdf:type schema:PropertyValue
69 N6e620db0bdf748f38b68e9348171eb72 rdf:first sg:person.01126413317.21
70 rdf:rest N974f4e6be5f54544b8c04d54e9352e4a
71 N7f5109159c1e4639b8c977482b463b88 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
72 schema:name Brain Neoplasms
73 rdf:type schema:DefinedTerm
74 N7f927da223cc45c79092c9c1d0a1cad9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
75 schema:name Research Design
76 rdf:type schema:DefinedTerm
77 N87a50a20d154421282c0cecf9e1c696d schema:issueNumber 1
78 rdf:type schema:PublicationIssue
79 N89190dcf70734be2819879eb9b5aa44a schema:name pubmed_id
80 schema:value 22436144
81 rdf:type schema:PropertyValue
82 N8e8908e8d51a461bb7f89c4c47a0e919 schema:name nlm_unique_id
83 schema:value 101265111
84 rdf:type schema:PropertyValue
85 N91414af384004d59bce7fbc715a2178b rdf:first sg:person.01002230243.29
86 rdf:rest N030359b112be473da547a5b8c028cda8
87 N974f4e6be5f54544b8c04d54e9352e4a rdf:first sg:person.0627666704.37
88 rdf:rest rdf:nil
89 Na7412f4c416f40b3920329db3b2ed27f rdf:first sg:person.0676000441.07
90 rdf:rest N91414af384004d59bce7fbc715a2178b
91 Na923d73be5ae458f8d07787ba5a48c4c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Cranial Irradiation
93 rdf:type schema:DefinedTerm
94 Nb93791d8a82a499e8621a02055c3468c schema:volumeNumber 7
95 rdf:type schema:PublicationVolume
96 Nd22e45a8df8342b69abb23bc4766e08e schema:name doi
97 schema:value 10.1186/1748-717x-7-42
98 rdf:type schema:PropertyValue
99 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
100 schema:name Medical and Health Sciences
101 rdf:type schema:DefinedTerm
102 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
103 schema:name Oncology and Carcinogenesis
104 rdf:type schema:DefinedTerm
105 sg:journal.1036451 schema:issn 1748-717X
106 schema:name Radiation Oncology
107 rdf:type schema:Periodical
108 sg:person.01002230243.29 schema:affiliation https://www.grid.ac/institutes/grid.39381.30
109 schema:familyName Yartsev
110 schema:givenName Slav
111 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01002230243.29
112 rdf:type schema:Person
113 sg:person.01126413317.21 schema:affiliation https://www.grid.ac/institutes/grid.16872.3a
114 schema:familyName Lagerwaard
115 schema:givenName Frank
116 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01126413317.21
117 rdf:type schema:Person
118 sg:person.01251570265.35 schema:affiliation https://www.grid.ac/institutes/grid.25073.33
119 schema:familyName Pond
120 schema:givenName Gregory R
121 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01251570265.35
122 rdf:type schema:Person
123 sg:person.01252126745.68 schema:affiliation https://www.grid.ac/institutes/grid.412745.1
124 schema:familyName Tay
125 schema:givenName Keng Yeow
126 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01252126745.68
127 rdf:type schema:Person
128 sg:person.0627666704.37 schema:affiliation https://www.grid.ac/institutes/grid.39381.30
129 schema:familyName Bauman
130 schema:givenName Glenn
131 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0627666704.37
132 rdf:type schema:Person
133 sg:person.0676000441.07 schema:affiliation https://www.grid.ac/institutes/grid.39381.30
134 schema:familyName Rodrigues
135 schema:givenName George
136 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0676000441.07
137 rdf:type schema:Person
138 https://doi.org/10.1016/0360-3016(89)90506-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022235183
139 rdf:type schema:CreativeWork
140 https://doi.org/10.1016/0360-3016(93)90367-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044677784
141 rdf:type schema:CreativeWork
142 https://doi.org/10.1016/0360-3016(95)02106-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1046204369
143 rdf:type schema:CreativeWork
144 https://doi.org/10.1016/j.ctrv.2005.04.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021728921
145 rdf:type schema:CreativeWork
146 https://doi.org/10.1016/j.ijrobp.2004.07.629 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003359041
147 rdf:type schema:CreativeWork
148 https://doi.org/10.1016/j.ijrobp.2005.05.023 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005827550
149 rdf:type schema:CreativeWork
150 https://doi.org/10.1016/j.ijrobp.2006.11.052 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010144498
151 rdf:type schema:CreativeWork
152 https://doi.org/10.1016/j.ijrobp.2007.06.074 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040065986
153 rdf:type schema:CreativeWork
154 https://doi.org/10.1016/j.ijrobp.2010.03.047 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025173793
155 rdf:type schema:CreativeWork
156 https://doi.org/10.1016/j.radonc.2011.05.032 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041892439
157 rdf:type schema:CreativeWork
158 https://doi.org/10.1016/s0140-6736(04)16250-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038506523
159 rdf:type schema:CreativeWork
160 https://doi.org/10.1016/s0167-8140(03)00117-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041826131
161 rdf:type schema:CreativeWork
162 https://doi.org/10.1016/s0360-3016(04)01933-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1054653816
163 rdf:type schema:CreativeWork
164 https://doi.org/10.1016/s0360-3016(96)00619-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014462056
165 rdf:type schema:CreativeWork
166 https://doi.org/10.1016/s0360-3016(99)00198-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038891858
167 rdf:type schema:CreativeWork
168 https://doi.org/10.1016/s0360-3016(99)00213-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003614610
169 rdf:type schema:CreativeWork
170 https://doi.org/10.1016/s0360-3016(99)00340-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047679955
171 rdf:type schema:CreativeWork
172 https://doi.org/10.1016/s1053-4296(99)80058-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004013743
173 rdf:type schema:CreativeWork
174 https://doi.org/10.1097/01.coc.0000245473.41035.c4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048339781
175 rdf:type schema:CreativeWork
176 https://doi.org/10.1118/1.1945347 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053586021
177 rdf:type schema:CreativeWork
178 https://doi.org/10.1259/bjr/22666727 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064568490
179 rdf:type schema:CreativeWork
180 https://www.grid.ac/institutes/grid.16872.3a schema:alternateName VU University Medical Center
181 schema:name Department of Radiation Oncology, VU University Medical Center, de Boelelaan 1117, 1081, HV Amsterdam, The Netherlands
182 rdf:type schema:Organization
183 https://www.grid.ac/institutes/grid.25073.33 schema:alternateName McMaster University
184 schema:name Department of Oncology, McMaster University and Escarpment Cancer Research Institute, L8V1C3, Hamilton, Ontario, Canada
185 rdf:type schema:Organization
186 https://www.grid.ac/institutes/grid.39381.30 schema:alternateName Western University
187 schema:name 790 Commissioners Rd. E, N6A4L6, London, ON, Canada
188 Department of Epidemiology and Biostatistics, University of Western Ontario, N6A3K7, London, ON, Canada
189 Department of Medical Biophysics, University of Western Ontario, N6A4L6, London, ON, Canada
190 Division of Radiation Oncology, Department of Oncology, University of Western Ontario and London Regional Cancer Program, London Health Sciences Centre,University of Western Ontario and London Regional Cancer Program, N6A4L6, London, ON, Canada
191 rdf:type schema:Organization
192 https://www.grid.ac/institutes/grid.412745.1 schema:alternateName London Health Sciences Centre
193 schema:name Department of Medical Imaging, London Health Sciences Centre, N6A4L6, London, ON, Canada
194 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...